Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
”Tumor Lysis Syndrome (TLS): Preventable, Yet Potentially Fatal
Tumor Lysis Syndrome remains one of the most critical oncologic emergencies in clinical practice. Rapid tumor cell breakdown can lead to severe metabolic disturbances, including hyperkalemia, hyperuricemia, and acute kidney injury, with potentially life-threatening consequences.
Importantly, TLS is no longer confined to high-grade lymphomas and acute leukemias. With the increasing use of targeted therapies, it is now recognized across a broader spectrum of malignancies.
Early risk stratification, close monitoring, and timely intervention, including hydration and appropriate use of agents such as rasburicase, are essential to improving patient outcomes.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?